blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2359840

EP2359840 - Use of pericyte apoptosis inhibitors for treating and/or preventing diabetic retinopathy [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  29.08.2014
Database last updated on 02.09.2024
Most recent event   Tooltip29.08.2014Application deemed to be withdrawnpublished on 01.10.2014  [2014/40]
Applicant(s)For all designated states
Merck Sante
37, rue Saint Romain
69379 Lyon Cedex 08 / FR
For all designated states
INSERM (Institut National de la Santé et de la Recherche Médicale)
101, rue de Tolbiac
75654 Paris Cedex 13 / FR
[2011/34]
Inventor(s)01 / Lecomte, Marc
Domaine de Bois-Dieu 12 allée des Coteaux
69380, Lissieu / FR
02 / Denis, Ulriche
411, allée du 11 Novembre 1918
69300, Caluire et Cuire / FR
03 / Paget, Clarisse
41, Fontaine au Roi
75011, Paris / FR
04 / Wiernsperger, Nicolas
920, rue du Paradis
69530, Orlienas / FR
05 / Lagarde, Michel
10, rue des Vignes
69150, Decines / FR
 [2011/34]
Representative(s)Novagraaf Technologies
Bâtiment O2
2, rue Sarah Bernhardt
CS90017
92665 Asnières-sur-Seine Cedex / FR
[N/P]
Former [2011/34]Novagraaf Technologies
122 rue Edouard Vaillant
92593 Levallois-Perret Cedex / FR
Application number, filing date11151829.624.10.2001
[2011/34]
Priority number, dateFR2000001364024.10.2000         Original published format: FR 0013640
[2011/34]
Filing languageFR
Procedural languageFR
PublicationType: A1 Application with search report 
No.:EP2359840
Date:24.08.2011
Language:FR
[2011/34]
Search report(s)(Supplementary) European search report - dispatched on:EP13.07.2011
ClassificationIPC:A61K38/06
[2011/34]
CPC:
A61K38/07 (EP,US); A61K31/00 (EP,US); A61K31/13 (EP,US);
A61K31/198 (EP,US); A61K31/7088 (EP,US); A61K38/06 (EP,US);
A61K38/08 (EP,US); A61K38/55 (EP,US); A61K45/06 (EP,US);
A61P27/02 (EP); A61P3/10 (EP) (-)
Designated contracting statesAT,   BE,   CH,   CY,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE,   TR [2011/34]
TitleGerman:Einsatz von Apoptosehemmern von Perizyten für die Behandlung und/oder Prävention der diabetes-bedingten Retinopathie[2011/34]
English:Use of pericyte apoptosis inhibitors for treating and/or preventing diabetic retinopathy[2011/34]
French:Utilisation d'inhibiteurs de l'apoptose des péricytes pour le traitement et/ou la prévention de la rétinopathie diabétique[2011/34]
Examination procedure24.01.2012Amendment by applicant (claims and/or description)
17.02.2012Examination requested  [2012/13]
08.06.2012Despatch of a communication from the examining division (Time limit: M04)
05.07.2012Reply to a communication from the examining division
01.05.2014Application deemed to be withdrawn, date of legal effect  [2014/40]
27.05.2014Despatch of communication that the application is deemed to be withdrawn, reason: renewal fee not paid in time  [2014/40]
Parent application(s)   TooltipEP01982545.4  / EP1343491
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued (EP20010982545) is  26.01.2009
Fees paidRenewal fee
24.01.2011Renewal fee patent year 03
24.01.2011Renewal fee patent year 04
24.01.2011Renewal fee patent year 05
24.01.2011Renewal fee patent year 06
24.01.2011Renewal fee patent year 07
24.01.2011Renewal fee patent year 08
24.01.2011Renewal fee patent year 09
24.01.2011Renewal fee patent year 10
18.10.2011Renewal fee patent year 11
28.09.2012Renewal fee patent year 12
Penalty fee
Additional fee for renewal fee
31.10.201313   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[Y]US5527533  (TSO MARK O M [US], et al) [Y] 12-15 * column 6, line 46 - column 7, line 25 * * column 9, lines 10-45 * * column 15, lines 15-23, 41-43 * * claims 1-27 *;
 [Y]US6103756  (GORSEK WAYNE F [US]) [Y] 12-15 * the whole document *;
 [XYI]WO0047218  (UNIV PENNSYLVANIA [US], et al) [X] 1-11,15 * abstract * * page 4, line 1 - page 5, line 28 * * page 23, lines 1-3 * * examples 1-3; claims 1-27 * [Y] 1-15 [I] 12-14;
 [YP]WO0074672  (US ARMY [US]) [YP] 12-15 * page 4, lines 16-28 * * page 6, line 2; claims 1-23 *;
 [XPYI]WO0139792  (ALCON UNIVERSAL LTD [CH], et al) [XP] 1-3,5,6,10 * the whole document * [Y] 1-15 [I] 4,7-9,11-15;
 [Y]  - ANSARI N H ET AL, "PREVENTION OF PERICYTE LOSS BY TROLOX IN DIABETIC RAT RETINA", JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH, US, (19980724), vol. 54, no. 6, doi:10.1080/009841098158755, ISSN 0098-4108, pages 467 - 475, XP001011588 [Y] 12 * abstract * * "Results", "Discussion";; figure 2 *

DOI:   http://dx.doi.org/10.1080/009841098158755
 [Y]  - KOLESNICK R N ET AL, "Regulation of ceramide production and apoptosis", ANNUAL REVIEW OF PHYSIOLOGY, ANNUAL REVIEWS, INC., PALO ALTO, CA, US, (19980101), vol. 60, doi:10.1146/ANNUREV.PHYSIOL.60.1.643, ISSN 0066-4278, pages 643 - 665, XP007906821 [Y] 12 * abstract * * page 644, paragraph 4 - page 645, paragraph 1 *

DOI:   http://dx.doi.org/10.1146/annurev.physiol.60.1.643
    [XPYI] - DENIS U ET AL, "ADVANCED GLYCATION END-PRODUCTS (AGE) INDUCE APOPTOSIS OF CULTURED BOVINE RETINAL PERICYTES: IMPLICATION OF CASPASES AND DAG/CERAMIDE PRODUCTION", DIABETES, AMERICAN DIABETES ASSOCIATION, US, (20010601), vol. 50, no. SUPPL. 02, ISSN 0012-1797, page A192, XP001064430 [XP] 1-3,5,6,9,11 * abstract * [Y] 1-15 [I] 4,7,8,10,12-15
 [Y]  - GARCIA-CALVO M ET AL, "Inhibition of human caspases by peptide-based and macromolecular inhibitors", JOURNAL OF BIOLOGICAL CHEMISTRY, THE AMERICAN SOCIETY OF BIOLOGICAL CHEMISTS, INC., BALTIMORE, MD, US, (19981204), vol. 273, no. 49, doi:10.1074/JBC.273.49.32608, ISSN 0021-9258, pages 32608 - 32613, XP002222060 [Y] 1-15 * abstract * * page 32608, column r, paragraph 3 * * page 32612, column r, paragraph 4 * * figure 1; tables 1,2 *

DOI:   http://dx.doi.org/10.1074/jbc.273.49.32608
 [A]  - H. R. STENNICKE, "Pro-caspase-3 Is a Major Physiologic Target of Caspase-8", JOURNAL OF BIOLOGICAL CHEMISTRY, (19981016), vol. 273, no. 42, doi:10.1074/jbc.273.42.27084, ISSN 0021-9258, pages 27084 - 27090, XP055001559 [A] 7 * table 1 *

DOI:   http://dx.doi.org/10.1074/jbc.273.42.27084
 [A]  - GREGOLI P A ET AL, "Function of caspases in regulating apoptosis caused by erythropoietin deprivation in erythroid progenitors", JOURNAL OF CELLULAR PHYSIOLOGY, WILEY LISS, NEW YORK, NY, US, (19990201), vol. 178, no. 2, doi:10.1002/(SICI)1097-4652(199902)178:2<133::AID-JCP2>3.0.CO;2-5, ISSN 0021-9541, pages 133 - 143, XP002471995 [A] 8 * page 135, column l, paragraph 2 *

DOI:   http://dx.doi.org/10.1002/(SICI)1097-4652(199902)178:2<133::AID-JCP2>3.0.CO;2-5
 [A]  - MASAKAZU MIZUTANI, "Accelerated death of retinal microvascular cells in human and experimental diabetic retinopathy.", J CLIN INVEST., (19960615), vol. 97, no. 12, pages 2883 - 2890, XP055001738 [A] 1-15 * page 2883, column r, lines 7-10, paragraph 1 *

DOI:   http://dx.doi.org/10.1172/JCI118746
 [A]  - Kohner, EM, "Diabetes and the eye", Kohner, EM, Easty, DL, Oxford textbook of ophthalmology, Oxford University Press, (19990101), vol. 2, XP009149782 [A] 1-15 * page 717, column l, paragraph 6 - column r, paragraph 1 *
 [A]  - KONDRATYEV ET AL, "Intracerebral injection of caspase-3 inhibitor prevents neuronal apoptosis after kainic acid-evoked status epilepticus", MOLECULAR BRAIN RESEARCH, (20000222), vol. 75, no. 2, doi:10.1016/S0169-328X(99)00292-2, ISSN 0169-328X, pages 216 - 224, XP055001438 [A] 1-15 * the whole document *

DOI:   http://dx.doi.org/10.1016/S0169-328X(99)00292-2
 [A]  - KNSTLE ET AL, "ICE-protease inhibitors block murine liver injury and apoptosis caused by CD95 or by TNF-alpha.", IMMUNOLOGY LETTERS, (19970101), vol. 55, no. 1, ISSN 0165-2478, pages 5 - 10, XP055001418 [A] 1-15 * the whole document *

DOI:   http://dx.doi.org/10.1016/S0165-2478(96)02642-9
by applicant   - AIELLO LP; GARDNER TW; KING GL; BLANKENSHIP G; CAVALLERANO JD; FERRIS FL; KLEIN R, "Diabetic retinopathy", DIABETES CARE, (1998), vol. 21, pages 277 - 293
    - ALGVERE PV; GOURAS P; DAFGARD KOPP E, "Long-term outcome of RPE allografts in non- immunosuppressed patients with AMD", EUR. J. OPHTHALMOL., (1999), vol. 9, pages 217 - 230
    - ALNEMRI ES, "Hidden powers of the mitochondria", NATURE CELL. BIOLOGY, (1999), vol. 1, pages 40 - 42
    - ALNEMRI ES; LIVINGSTON DJ; NICHOLSON DW; SALVESEN G; THORNBERRY NA; WONG WW; YUAN J, "Human ICE/CED-3 Protease Nomenclature", CELL, (1996), vol. 87, page 171
    - ANDRIEU N; SALVAYRE R; LEVADE T, "Evidence Against Involvement of the acid lysosomal Sphingomyelinase in the TNF and Interleukin-1-induced Sphingomyelin Cycle and Cell Proliferation in Human Fibroblasts", BIOCHEM. J., (1994), vol. 303, pages 341 - 345
    - ANSARI NH; ZHANG W; FULEP E; MANSOUR A, "Prevention of pericyte loss by trolox in diabetic rat retina", J. TOXICOL. ENVIRONM. HEALTH, (1998), vol. 54, pages 467 - 478
    - BEISSWENGER PJ; MAKITA Z; CURPHEY TJ; MOORE LL; SMITH J; BRINCK-JOHNSEN T; BUCALA R; VLASSARA H, "Formation of Immunochemical Advanced Glycosylation End Products Precedes and Correlate with Early Mannifestations of Renal and Retinal Diseases in Diabetes", DIABETES, (1995), vol. 44, pages 824 - 829
    - BIERHAUS A; CHEVION S; CHEVION M; HOFMANN M; QUEHENBERGER P; ILLMER T; LUTHER T; BERENTSHTEIN E; TRITSCHLER H; MULLER M, "Advanced glycation end product-induced activation of NF-KB is suppressed by a-lipoic acid in cultured endothelial cells", DIABETES, (1997), vol. 46, pages 1481 - 1490
    - BLIGH EG; DYER WJ, "A rapid method of total lipid extraction and purification", CAN. J. BIOCHEM. PHYSIOL., (1959), vol. 37, pages 911 - 917
    - BRETT J; SCHMIDT AM; YAN SD; ZOU YS; WEIDMAN E; PINSKY D; NOWYGROD R; NEEPER M; PRZYSIECKI C; SHAW A, "Survey of the distribution of a newly characterized receptor for advanced glycation end products in tissues", AM. J. PATHOL., (1993), vol. 143, pages 1699 - 1712
    - CHIBBER R; MOLINATI PA; ROSATTO N; LAMBOURNE B; KOHNER EM, "Toxic action of Advanced Glycation End Products on Cultured Retinal Capillary Pericytes and Endothelial Cells: Relevance to Diabetic Retinopathy", DIABETOLOGIA, (1997), vol. 40, pages 156 - 164
    - COGAN DG; TOUSSAINT D; KUWABARA T, "Retinal vascular patterns IV. Diabetic retinopathy", ARCH. OPHTHALMOL, (1961), vol. 60, pages 100 - 112
    - "DCCT - The Diabetes Control Complications Trial Research Group. The effects of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus", N ENGL J MED, (1993), vol. 239, pages 977 - 986
    - DEGENHARDT TP; THORPE SR; BAYNES JW, "Chemical modification of Proteins by Methylglyoxal", CELL. MOL. BIOL., (1998), vol. 44, pages 1139 - 1145
    - DESAI SD; BLANCHARD J, "In vitro evaluation of pluronicF127-based controlled-release ocular delivery systems for pilocarpine", J. PHARM. SCI., (1998), vol. 87, pages 226 - 230
    - DUAN H; CHINNAIYAN AM; HUDSON PL; WING JP; HE WW; DIXIT VM, "ICE-LAP3, a novel Mammalian Homologue of Caenorhabditis elegans Cell Death Protein Ced-3 is Activated During Fas- and TNF-induced Apoptosis", J. BIOL. CHEM., (1996), vol. 271, pages 1621 - 1624
    - DUAN H; ORTH K; CHINNAIYAN AM; POIRIER GG; FROELICH CJ; HE WW; DIXIT WM, "ICE-LAP6, a Novel Member of the ICE/Ced-3 Gene Family, is Activated by Cytotoxic T Cell Protease Gramzyme B", J. BIOL. CHEM., (1996), vol. 271, pages 16720 - 16724
    - "Early Treatment Diabetic Retinopathy Study Research group : grading diabetic retinopathy from stereoscopic color fundus photographs : an extension of the modified Airlie House classification : ETDRS Report n°10", OPHTHALMOLOGY, (1991), vol. 98, pages 786 - 791
    - FERNANDES-ALNEMRI T; ARMSTRONG RT; KREBS J; SRINIVASULA SM; WANG L; BULLRICH F; FRITZ LC; TRAPANI JA; TOMASELLI KJ; LITWACK G, "In vitro Activation of CPP32 and Mch3 by Mch4, a Novel Apoptotic Cysteine Protease Containing Two FADD-like Domains", PROC. ACAD. NATL. SCI. USA, (1995), vol. 93, pages 7464 - 7469
    - FRANK RN, Diabetic retinopathy. Chapter 1 in Progress in Retinal and Eye Research, ELSEVIER SCIENCE LTD, (1995), vol. 14, pages 361 - 392
    - FREEDMAN KA; KLEIN JW; CROSSON CE, "Beta-cyclodextrins enhance bioavailability of pilocarpine", CURR. EYE RES., (1993), vol. 12, pages 641 - 647
    - FRIEDENWALD JS, "Diabetic retinopathy", AM. J. OPHTHALMOL., (1950), vol. 33, pages 1187 - 1199
    - FRIEDERICH RL, "The pilocarpine Ocusert: a new drug delivery system", ANN. OPHTHALMOL., (1974), vol. 6, pages 1279 - 1284
    - GARCIA-CALVO M; PETERSON EP; LEITING B; RUEL R; NICHOLSON DW; THORNBERRY NA, "Inhibition of Human Caspases by Peptide-based and Macromolecular Inhibitors", J. BIOL. CHEM., (1998), vol. 273, pages 32608 - 32613
    - GENESTIER L; PRIGENT A-F; PAILLOT R; QUEMENEUR L; DURAND I; BANCHEREAU J; REVILLARD JP; BONNEFOY-BéRARD N, "Caspase-dependant ceramide Production in FAS- and HLA Class I-mediated Peripheral T Cell Apoptosis", J. BIOL. CHEM., (1998), vol. 273, pages 5060 - 5066
    - GLUZMAN Y; REICHL H; SOLNICK D, Eukaryotic Viral Vectors, COLD SPRING HARBOR LABORATORY, (1982), pages 187 - 192
    - GRAHAM FL; SMILEY J; RUSSEL WC; NAIRN R, "Characteristics of a human cell line transformed by DNA from human adenovirus type 5", J. GEN. VIROL., (1977), vol. 36, pages 59 - 74
    - HAMMES HP; MARTIN S; FEDERLIN K; GEISEN K; BROWNLEE M, "Aminoguanidine Treatment inhibits the Development of Experimental Diabetic Retinopathy", PROC. NATL., ACAD. SCI. USA, (1991), vol. 88, pages 11555 - 11558
    - HANGAI M; TANIHARA H; HONDA Y; KANEDA Y, "In Vivo delivery of phosphorothioate oligonucleotides into the murine retina", ARCH. OPHTHALMOL., (1998), vol. 116, pages 342 - 348
    - JAFFREZOU JP; CHEN G; DURAN GE; MULLER C; BORDIER C; LAURENT G; SIKIC BI; LEVADE T, "Inhibition of lysosomal acid sphingomyelinase by agents which reverse multidrug resistance", BIOCHIM. BIOPHYS. ACTA, (1995), vol. 1266, pages 1 - 8
    - KAHN HA; HILLER R, "Blindness caused by diabetic retinopathy", AM. J. OPHTHALMOL., (1974), vol. 78, pages 58 - 67
    - KARESH JW, "Polytetrafluoroethylene as a graft material in ophthalmic plastic and reconstructive surgery. An experimental and clinical study", OPHTHAL. PLAST. RECONSTR. SURG., (1987), vol. 3, pages 179 - 185
    - KUWABARA T; COGAN DG, "Retinal vascular patterns VI. Mural cells of the retinal capillaries", ARCHS. OPHTHAL., (1963), vol. 69, pages 492 - 502
    - LAI CM; SHEN WY; ONSTABLE I; RAKOCZY PE, "The use of adenovirus-mediated gene transfer to develop a rat model for photoreceptor degeneration", INVEST. OPHTHALMOL. VIS. SCI., (2000), vol. 41, pages 580 - 584
    - LANDER HM; TAURAS JM; OGISTE JS; HORI O; MOSS RA; SCHMIDT AM, "Activation of the receptor for advanced glycation end products triggers a p21ras- dependent mitogen-activated protein kinase pathway regulated by oxidant stress", J. BIOL. CHEM., (1997), vol. 272, pages 17810 - 17814
    - LEAHEY AB; GOTTSCH JD; SYARK WJ, "Clinical experience with N-butyl cyanoacrylate (Nexacryl) tissue adhesive", OPHTHALMOL., (1993), vol. 100, pages 173 - 180
    - LECOMTE M; PAGET C; RUGGIERO D; WIERNSPERGER N; LAGARDE M, "Docosahexaenoic acid is a major n-3 polyunsaturated fatty acid in bovine retinal microvessels", J. NEUROCHEM., (1996), vol. 66, pages 2160 - 2167
    - LEEDS JM; HENRY SP; BISTNER S; SCHERILL S; WILLIAMS K; LEVIN AA, "Pharmacokinetics of an antisense oligonucleotide injected intravitreally in monkeys", DRUG METAB. DISPOS., (1998), vol. 26, pages 670 - 675
    - LI W; LIU X; YANOFF M; COHEN S; YE X, "Cultured Retinal Capillary Pericytes Die by Apoptosis After an Abrupt Fluctuation from High to Low Glucose Levels: a Comparative Study With Retinal Capillary Endothelial Cells", DIABETOLOGIA, (1996), vol. 39, pages 537 - 547
    - LI W; LIU X; HE Z; YANOFF M; JIAN B; YE X, "Expression of Regulatory genes by Retinal Pericytes After Rapid Glucose Reduction", SCI., (1998), vol. 39, pages 1535 - 1543
    - LI W; YANOFF M; JIAN B; HE Z, "Altered mRNA levels of antioxidant enzymes in pre-apoptotic pericytes from human diabetic retinas", CELL. MOL. BIOL. (NOISY-LE-GRAND), (1999), vol. 45, pages 59 - 66
    - LI W; SHEN S; KHATAMI M; ROCKEY JH, "Stimulation of retinal capillary pericyte protein and collagen synthesis in culture by high glucose concentration", DIABETES, (1984), vol. 33, pages 785 - 789
    - LI W; YANOFF M; LIU X; YE X, "Retinal Capillary Pericytes Apoptosis in Early Diabetic Retinopathy", CHIN. MED. J (ENGL), (1997), vol. 110, pages 659 - 663
    - LO TWC; WESTWODD ME; MCLELLAN AC; SELWOLL T; THORNALLEY PJ, "Binding and modification of proteins by methylglyoxal under physiological conditions. A kinetic and mechanistic study with N?-acetylarginine, Na- acetylcysteine, Na-acetyllysine, and bovine serum albumin", J. BIOL. CHEM., (1994), vol. 269, pages 32299 - 32305
    - MAILLARD LC, "Action des acides aminés sur les sucres : formation des mélanoïdines par voie méthodique 1912", C R HEBD SCI, ACAD SCI PARIS, vol. 154, pages 66 - 68
    - MANDARINO LJ; SUNDARRAJ N; FINLAYSON J; HASSEL JR, "Regulation of fibronectin and laminin synthesis by retinal capillary endothelial cells and pericytes in vitro", EXP. EYE RES., (1993), vol. 57, pages 609 - 621
    - MATHIAS S; PENA LA; KOLESNICK RN, "Signal transduction of stress via ceramides", BIOCHEM. J., (1998), vol. 335, pages 465 - 480
    - MCLELLAN AC; THORNALLEY PJ; BENN J; SONKSEN PH, "Glyoxalase System in Clinical Diabetes Mellitus and Correlation with Diabetic Complications", CLIN. SCI., (1994), vol. 7, pages 21 - 29
    - MIZUTANI M; KERN TS; LORENZY M, "Accelerated Death of Retinal Microvascular Cells in Human and Experimental Diabetic. Retinopathy", J. CLIN. INVEST., (1996), vol. 97, pages 2883 - 2890
    - MüLLER-DECKER K; DOPPLER C; AMTMANN E; SAUER G, "Interruption of Growth Signal Transduction by an Antiviral and Antitumoral Xanthate compound", EXP. CELL. RES., (1988), vol. 177, pages 295 - 302
    - MùLLER-DECKER K, "Interruption of TPA-induced Signals by an Antiviral and Antitumoral Xanthate Compound: Inhibition of a Phospholipase C-type Reaction", BIOCHEM. BIOPHYS. RES. COM., (1989), vol. 162, pages 198 - 205
    - NATHAN DM; FOGEL HA; GODINE JE ET AL., "Role of diabetologist in evaluating diabetic retinopathy", DIABETES CARE, (1991), vol. 14, pages 26 - 33
    - NEEPER M; SCHMIDT AM; BRETT J; YAN SD; WANG F; PAN YC; ELLISTON K; STERN D; SHAW A, "Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins", J. BIOL. CHEM., (1992), vol. 267, pages 14498 - 15004
    - NICHOLSON DW; ALI A; THORNBERRY NA; VAILLANCOURT JP; DINK CK; GALLANT M; GAREAU Y; GRIFFIN PR; LABELLE M; LAZEBNICK YA, "Identification and Inhibition of the ICE/CED-3 Protease Necessary for Mammalian Apoptosis", NATURE, (1995), vol. 376, pages 37 - 43
    - NISHIKAWA T; EDELSTEIN D; HU XL; YAMAGISHI SI; MATSUMURA T; KANEDA Y; YORAK MA; BEEBE D; DATES PJ; HAMMES PJ, "Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage", NATURE, (2000), vol. 404, pages 787 - 790
    - NUNEZ G; BENEDICT MA; HU Y; INOHARA N, "Caspases: the proteases of the apoptotic pathway", ONCOGENE, (1998), vol. 17, pages 3237 - 3245
    - NUYTS RM; KOOIJMAN-DEGROOT MJ; PRINS ET PELS E, "Use of a polyurethane patch for temporary closure of a sterile corneal perforation", ARCH. OPHTALMOL., (1999), vol. 117, pages 1427 - 1429
    - OGANESIAN A; GABRIELIAN K; ERNEST JT; PATEL SC, "A new model of retinal pigment epithelium transplantation with microspheres", ARCH. OPHTHALMOL., (1999), vol. 117, pages 1192 - 1200
    - OKASAKI T; KONDO T; KITANO T; TASHIMA M, "Diversity and Complexity of Ceramides Signaling in Apoptosis", CELL. SIGNAL., (1998), vol. 10, pages 685 - 692
    - PAGET C; LECOMTE M; RUGGIERO D; WIERNSPERGER N; LAGARDE M, "Modification of Enzymatic Antioxidants in Retinal Microvascular by glucose or Advanced Glycation End Products", FREE. RADIC. BIOL. MED., (1998), vol. 25, pages 121 - 129
    - PALMBERG PF, "Diabetic retinopathy", DIABETES, (1977), vol. 26, pages 703 - 709
    - PODESTA F; ROMEO G; LIU WH; KRAJEWSKI S; REED JC; GERHARDINGER C; LORENZY M, "Bax is Increased in the Retina of Diabetic Subjects and in Associated With Pericytes Apoptosis In Vivo and In Vitro", AM. J. PATHOL., (2000), vol. 156, pages 1025 - 1032
    - PORTA M; MOLINATTI PA; DOSSO AA; WILLIAMS FMK; BROOKS RA; KOHNER EM, "Growth of bovine retinal pericytes and endothelial cells in high glucose concentrations", DIABETES AND METABOLISM, (1994), vol. 20, pages 25 - 30
    - PREISS J; LOOMIS CR; BISHOP WR; STEIN R; NIEDEL JE; BELL RM, "Quantitative measurement of sn-1,2-diacylglycerols present in platelets, hepatocytes, and ras- and sis-transformed normal kidney cells", J. BIOL. CHEM., (1986), vol. 261, pages 8597 - 8600
    - RUBIN AL; STENZEL KH; MIYATA T; WHITE MJ; DUNN M, "Collagen as a vehicle for drug delivery. Preliminary report", J. CLIN. PHARMACOL., (1973), vol. 13, pages 309 - 312
    - RUGGIERO-LOPEZ D; RELLIER N; LECOMTE M; LAGARDE M; WIERNSPERGER N, "Growth Modulation of Retinal Microvascular Cells by Early and Advanced Glycation Products", DIABETES RES. CLIN. PRACT., (1997), vol. 34, pages 135 - 142
    - SCHAFFNER W; WEISSMANN C, "A rapid, sensitive and specific method for the determination of protein in dilute solution", ANAL. BIOCHEM., (1973), vol. 50, pages 502 - 504
    - SCHALKWIJCK CG; LIGTVOET N; TWAALFHOVEN H; JAGER A; BLAAUWGEERS HGT; SCHLINGEMANN RO; TARNOW L; PARVING HH; STEHOUWER CDA; VAN HIN, "Amadori Albumin in Type I diabetic patients. Correlation with markers of endothelial function, association with diabetic nephropathy, and localization in retinal capillaries", DIABETES, (1999), vol. 48, pages 2446 - 2453
    - SCHMIDT AM; VIANNA M; GERLACH M; BRETT J; RYAN J; KAO J; ESPOSITO C; HEGARTY H; HURLEY W; CLAUSS M, "Isolation and characterization of two binding proteins for advanced glycosylation end products from bovine lung which are present on the endothelial cell surface", J. BIOL. CHEM., (1992), vol. 267, pages 14987 - 14997
    - SCHUCHMAN EH; SUCHI M; TAKAHASHI T; SANDHOFF K; DESNICK RJ, "Human acid sphingomyelinase. Isolation, nucleotide sequence and expression of the full-length and alternatively spliced cDNAs", J. BIOL. CHEM., (1991), vol. 266, pages 8531 - 8539
    - SCHüTZE S; POTTHOFF K; MACHLEIDT T; BERKOVIC D; WIEGMANN K; KRôNKE M, "TNF Activates NF-kB by Phosphatidylcholine-specific Phospholipase C-Induced "Acidic" Sphingomyelin Breakdown", CELL, (1992), vol. 71, pages 765 - 776
    - SHINOHARA M; THORNALLEY PJ; GIARDINO I; BEISSWENGER P; THORPE SR; ONORATO J; BROWNLEE M, "Overexpression of glyoxalase-I in bovine endothelial cells inhibits intracellular advanced glycation endproduct formation and prevents hyperglycemia-induced increases in macromolecular endocytosis", J. CLIN. INVEST., (1998), vol. 101, pages 1142 - 1147
    - SOULIS T; THALLAS V; YOUSSEF S; GILBERT RE; MCWILLIAM BG; MURRAY-MCITOSH RP; COOPER ME, "Advanced glycation end products and their receptors co- localise in rat organs susceptible to diabetic microvascular injury", DIABETOLOGIA, (1997), vol. 40, pages 619 - 628
    - STENNICKE HR; SALVESEN GS, "Properties of the caspases", BIOCHIM. BIOPHYS. ACTA, (1998), vol. 1387, pages 17 - 31
    - STITT AW; LI YM; GARDINER TA; BUCALA R; ARCHER DB; VLASSARA H, "Advanced Glycation End Products (AGEs) Co-localize With AGE Receptors in the Retinal Vasculat'ure of Diabetic and AGE-infused Rats", AM. J. PATHOL., (1997), vol. 150, pages 523 - 535
    - SU T; GILLIES MC, "A simple method for the in vitro culture of human retinal capillary endothelial cells", INVEST. OPHTHALMOL. VIS. SCI., (1992), vol. 33, pages 2809 - 2813
    - THORNALLEY PJ, "Cell activation by glycated proteins. AGE receptors, receptor recognition factors and functional classifications of AGEs", CELL. MOL. BIOL. (NOISY-LE-GRAND), (1998), vol. 44, pages 1013 - 1023
    - THORNALLEY PJ, "The clinical significance of glycation", CLIN. LAB., (1999), vol. 45, pages 261 - 273
    - THORNBERRY NA; RANO TA; PETERSON ER; RASPER DM; TIMKEY T; GARCIA-CALVO M; HOUTZAGER VM; NORDSTROM PA; ROY S; VAILLANCOURT JP, "A combinatorial Approach Defines Specificities of Members of the Caspase Family and Granzymes B", J. BIOL. CHEM., (1997), vol. 272, pages 17907 - 17911
    - "UKPDS(a)- UK Prospective Diabetes Study Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)", LANCET, (1998), vol. 352, no. 9131, pages 837 - 853
    - "UKPDS(b)- UK Prospective Diabetes Study Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)", LANCET, (1998), vol. 352, no. 9131, pages 854 - 865
    - VANDERVOORT J; LUDWIG A, "Evaluation of pilocarpine loaded gelatin particles for topical ophthalmic use", J. PHARM. BELG., (1999), vol. 54, pages 85 - 86
    - VLASSARA H; LI Y-M; IMANI F; WOJCIECHOWICZ D; YANG Z; LIU FT; CERAMI A, "Identification of galectin-3 as a high-affinity binding protein for advanced glycation end products (AGE): a new member of the AGE- receptor complex", MOL. MED., (1995), vol. 1, pages 634 - 646
    - WANG E; NORRED WP; BACON CW; RILEY RT; MIRRILL AH JR, "Inhibition of Sphingolipid Biosynthesis by Fumonisins. Implication for Diseases Associated with Fusarium Monoliforme", J. BIOL. CHEM., (1991), vol. 266, pages 14486 - 14490
    - WESTWOOD ME; THORNALLEY PJ, "Molecular characteristics of methylglyoxal-modified bovine and human serum albumins. Comparison with glucose-derived advanced glycation endproducts-modified serum albumins", J. PROTEIN CHEM., (1995), vol. 14, pages 359 - 372
    - WILKINS MR; OCCLESTON NL; KOTECHA A; WATERS L; KHAW PT, "Sponge delivery variables and tissues levels of 5-fluorouracil", BR. J. OPHTHALMOL., (2000), vol. 84, pages 92 - 97
    - YAMAGISHI S; HSU CC; TANIGUCHI M HARADA S; YAMAMOTO Y; OHSAWA K; KOBAYASHI K; YAMAMOTO H, "Receptor mediated Toxicity to Pericytes of Advanced Glycosylation End Products: a Possible Mechanism of Pericyte Loss in Diabetic Microangiopathy", BIOCHEM. BIOPHYS. RES. COMMUN., (1995), vol. 213, pages 681 - 687
    - YAN SD; SCHMIDT AM; ANDERSON GM; ZHANG J; BRETT J; ZOU YS; PINSKY D; STERN D, "Enhanced cellular oxidant stress by the interaction of advanced glycation end producys with their receptors/binding proteins", J. BIOL. CHEM., (1994), vol. 269, pages 9889 - 9897
    - YANG BZ; MAKITA Z; HORII Y; BRUNELLE S; CERAMI A; SEHAJPAL P; SUTHANTHIRAN M; VLASSARA H, "Two novel rat liver membrane proteins that bind advanced glycosylation end products: relationship to macrophage receptor for glucose-modified proteins", J. EXP. MED., (1991), vol. 174, pages 515 - 524
    - ZHU G; MALLERY SR; SCHWENDEMAN SP, "Stabilization of proteins encapsulated in injectable poly(lactide-co-glycolide)", NATURE BIOTECHNOL., (2000), vol. 18, pages 52 - 57
    - ZUCKERT WR; MARQUIS H; GOLDFINE H, "Modulation of enzymatic activity and biological function of Listeria monocytogenes broad-range phospholipase C by amino acid substitution and by replacement with the Bacillus cereus ortholog", INFECT. IMMUN., (1998), vol. 66, pages 4823 - 4831
    - ZUROWSKA-PRYCZKOWSKA K; SZNITOWSKA M; JANICKI S, "Studies on the effect of pilocarpine incorporation into a submicron emulsion on thé stability of the drug and the vehicle", EUR. J. PHARM. BIOPHARM., (1999), vol. 47, pages 255 - 260
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.